BBIO
Price
$24.79
Change
+$0.17 (+0.69%)
Updated
Nov 13 closing price
98 days until earnings call
LIXT
Price
$1.64
Change
-$0.04 (-2.38%)
Updated
Nov 13 closing price
Ad is loading...

BBIO vs LIXT

Header iconBBIO vs LIXT Comparison
Open Charts BBIO vs LIXTBanner chart's image
BridgeBio Pharma
Price$24.79
Change+$0.17 (+0.69%)
Volume$1.83M
CapitalizationN/A
Lixte Biotechnology Holdings
Price$1.64
Change-$0.04 (-2.38%)
Volume$13.82K
CapitalizationN/A
BBIO vs LIXT Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BBIO vs. LIXT commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and LIXT is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (BBIO: $24.79 vs. LIXT: $1.65)
Brand notoriety: BBIO and LIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 99% vs. LIXT: 2%
Market capitalization -- BBIO: $4.66B vs. LIXT: $3.71M
BBIO [@Biotechnology] is valued at $4.66B. LIXT’s [@Biotechnology] market capitalization is $3.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileLIXT’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • LIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than LIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 4 TA indicator(s) are bullish.

  • BBIO’s TA Score: 4 bullish, 4 bearish.

Price Growth

BBIO (@Biotechnology) experienced а -3.20% price change this week, while LIXT (@Biotechnology) price change was -8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 20, 2025.

LIXT is expected to report earnings on May 10, 2023.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($4.66B) has a higher market cap than LIXT($3.71M). LIXT YTD gains are higher at: -29.787 vs. BBIO (-38.593). LIXT has higher annual earnings (EBITDA): -4.01M vs. BBIO (-368.14M). BBIO has more cash in the bank: 448M vs. LIXT (2.6M). LIXT has less debt than BBIO: LIXT (100K) vs BBIO (1.73B). BBIO has higher revenues than LIXT: BBIO (219M) vs LIXT (0).
BBIOLIXTBBIO / LIXT
Capitalization4.66B3.71M125,600%
EBITDA-368.14M-4.01M9,177%
Gain YTD-38.593-29.787130%
P/E RatioN/AN/A-
Revenue219M0-
Total Cash448M2.6M17,264%
Total Debt1.73B100K1,729,000%
FUNDAMENTALS RATINGS
LIXT: Fundamental Ratings
LIXT
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIO
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AREC1.230.12
+10.81%
American Resources Corp
PCSA1.07N/A
N/A
Processa Pharmaceuticals
UNM71.02-0.28
-0.39%
Unum Group
SWBI13.01-0.20
-1.51%
Smith & Wesson Brands
ZETA17.76-10.46
-37.07%
Zeta Global Holdings Corp

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with BPMC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+0.69%
BPMC - BBIO
48%
Loosely correlated
+0.27%
ARGX - BBIO
46%
Loosely correlated
+0.88%
AXON - BBIO
44%
Loosely correlated
+1.05%
ARRY - BBIO
43%
Loosely correlated
+1.97%
ALDX - BBIO
43%
Loosely correlated
-7.36%
More

LIXT and

Correlation & Price change

A.I.dvisor tells us that LIXT and HSTO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIXT and HSTO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-1.79%
HSTO - LIXT
29%
Poorly correlated
N/A
NTLA - LIXT
28%
Poorly correlated
-3.24%
IBIO - LIXT
28%
Poorly correlated
-9.02%
BBIO - LIXT
27%
Poorly correlated
+0.69%
PMN - LIXT
26%
Poorly correlated
N/A
More